Bibliography Ralf Bender's Selected Bibliography

Go to:   - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 and before -

Line

  1. BENDER, R.(2012):
    Adequate methods should be used to compare the features of effect measures.
     J. Clin. Epidemiol. 65 (in press).
  2. BENDA, N. & BENDER, R.(2011):
    Multiplicity issues in clinical trials.
     Biom. J. 53, 873-874.
  3. BENDER, R. & VERVÖLGYI, V. (2011):
    Die Berechnung adjustierter NNTs in randomisierten kontrollierten Studien.
    In: ORTSEIFEN, C., RAMROTH, H., WEIRES, M. & MINKENBERG, R. (Eds.): KSFE 2011 − Voneinander lernen”, Proceedings der 15. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), Ruprechts-Karls-Universität Heidelberg, 24.-25.02.2011, pp. 51-58.  Shaker, Aachen.   Open Access
  4. VERVÖLGYI, E., KROMP, M., SKIPKA, G., BENDER, R. & KAISER, T.(2011):
    Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: A literature survey.
    BMC Med. Res. Methodol. 11, 130.   Open Access
  5. BENDER, R., KOCH, A., SKIPKA, G., KAISER, T. & LANGE, S. (2011):
    The assessment of heterogeneity is mandatory in clinical trials and systematic reviews.
    J. Clin. Epidemiol. 64, 452.
  6. BENDER, R., KOCH, A., SKIPKA, G., KAISER, T. & LANGE, S (2010):
    No inconsistent trial assessments by NICE and IQWiG: Different assessment goals may lead to different assessment results regarding subgroup analyses.
     J. Clin. Epidemiol. 63, 1305-1307.
  7. SKIPKA, G. & BENDER, R. (2010):
    Assessment of intervention effects in the case of heterogeneity between three subgroups within the framework of systematic reviews.
    Meth. Inf. Med. 49, 613-617.
  8. GEHRMANN, U., KUSS, O., WELLMANN, J. & BENDER, R. (2010):
    Logistic regression was preferred to estimate risk differences and numbers needed to be exposed adjusted for covariates.
    J. Clin. Epidemiol. 63, 1223-1231.
  9. BENDER, R. (2010):
    Using and interpreting adjusted NNT measures in biomedical research.
    Open Dent. J. 4, 72-76.   Open Access
  10. BENDER, R. & VERVÖLGYI, V. (2010):
    Estimating adjusted NNTs in randomised controlled trials with binary outcomes: A simulation study.
    Contemp. Clin. Trials 31, 498-505.
  11. STANG, A., POOLE, C. & BENDER, R. (2010):
    Common problems related to the use of number needed to treat.
    J. Clin. Epidemiol. 63, 820-825.
  12. HORVATH, K., KOCH, K., JEITLER, K., MATYAS, E., BENDER, R., BASTIAN, H., LANGE, S. & SIEBENHOFER, A. (2010):
    Effects of treatment in women with gestational diabetes mellitus: Systematic review and meta-analysis.
    BMJ 340, c1395.   Open Access
  13. LAUBENDER, R.P. & BENDER, R. (2010):
    Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model.
    Stat. Med. 29, 851-859.
  14. BENDER, R. & KUSS, O. (2010):
    Methods to calculate relative risks, risk differences, and numbers needed to treat from logistic regression.
    J. Clin. Epidemiol. 63, 7-8.
  15. GROUVEN, U., HEMKENS, L.G., BENDER, R. & SAWICKI, P.T. (2010):
    Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter].
    Diabetologia 53, 209-211.
  16. HEMKENS, L.G., BENDER, R., GROUVEN, U. & SAWICKI, P.T. (2009):
    Insulin glargine and cancer.
    Lancet 374, 1743-1744.   Open Access
  17. HEMKENS, L.G., GROUVEN, U., BENDER, R., GÜNSTER, C., GUTSCHMIDT, S., SELKE, G.W. & SAWICKI, P.T. (2009):
    Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study.
    Diabetologia 52, 1732-1744.   Open Access
  18. HILDEBRANDT, M., VERVÖLGYI, E. & BENDER, R. (2009):
    Calculation of NNTs in RCTs with time-to-event outcomes: A literature review.
    BMC Med. Res. Methodol. 9, 21.   Open Access
  19. LÜHRMANN, P.M., BENDER, R., EDELMANN-SCHÄFER, B. & NEUHÄUSER-BERTHOLD, M. (2009):
    Longitudinal changes in energy expenditure in an elderly German population: A 12 year follow-up.
    Eur. J. Clin. Nutr. 63, 986-992.
  20. BENDER, R. (2009):
    Introduction to the use of regression models in epidemiology.
    In: VERMA, M. (Ed.): Cancer Epidemiology, Vol. 1: Host Susceptibility Factors, pp. 179-195.  Humana Press, Totowa, NJ.
  21. GROUVEN, U., KÜCHENHOFF, H., SCHRÄDER, P. & BENDER, R. (2008):
    Flexible regression models are useful tools to calculate and assess threshold values in the context of minimum provider volumes.
    J. Clin. Epidemiol. 61, 1125-1131.
  22. BENDER, R. & GROUVEN, U. (2008):
    Berechnung von Konfidenzintervallen für die Population Impact Number (PIN).
    In: HILGERS, R.-D., HEUSSEN, N., HERFF, W. & ORTSEIFEN, C. (Eds.): KSFE 2008 − Proceedings der 12. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), pp. 41-47.  Shaker, Aachen.   Open Access
  23. BENDER, R., BUNCE, C., CLARKE, M., GATES, S., LANGE, S., PACE, N.L. & THORLUND, K. (2008):
    Attention should be given to multiplicity issues in systematic reviews.
    J. Clin. Epidemiol. 61, 857-865.
  24. BENDER, R. (2007):
    Simulation von Überlebenszeiten mit Hilfe von SAS®.
    In: MUCHE, R. & BÖDEKER, R.-H. (Eds.): KSFE 2007 − Proceedings der     11. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), pp. 55-62.  Shaker, Aachen.   Open Access
  25. BENDER, R., KUSS, O., HILDEBRANDT, M. & GEHRMANN, U. (2007):
    Estimating adjusted NNT measures in logistic regression analysis.
    Stat. Med. 26, 5586-5595.
  26. SCHRÄDER, P., GROUVEN, U. & BENDER, R. (2007):
    Können Mindestmengen für Knieprothesen anhand von Routinedaten errechnet werden? Ergebnisse einer Schwellenwertanalyse mit Daten der externen stationären Qualitätssicherung.
    Orthopäde 36, 570-576.
  27. LANGE, S. & BENDER, R. (2007):   Median oder Mittelwert?   Dtsch. Med. Wschr. 132, e1-e2.   Open Access
  28. LANGE, S. & BENDER, R. (2007):   Quantile, empirische Verteilungsfunktion und Box Plot.   Dtsch. Med. Wschr. 132, e3-e4.   Open Access
  29. LANGE, S. & BENDER, R. (2007):   Variabilitätsmaße.   Dtsch. Med. Wschr. 132, e5-e6.   Open Access
  30. LANGE, S. & BENDER, R. (2007):   Das Histogramm.   Dtsch. Med. Wschr. 132, e7-e8.   Open Access
  31. LANGE, S. & BENDER, R. (2007):   Lineare Regression und Korrelation.   Dtsch. Med. Wschr. 132, e9-e11.   Open Access
  32. BENDER, R. & LANGE, S. (2007):   Die Vierfeldertafel.   Dtsch. Med. Wschr. 132, e12-e14.   Open Access
  33. BENDER, R. & LANGE, S. (2007):   Was ist der p-Wert?   Dtsch. Med. Wschr. 132, e15-e16.   Open Access
  34. BENDER, R. & LANGE, S. (2007):   Was ist ein Konfidenzintervall?   Dtsch. Med. Wschr. 132, e17-e18.   Open Access
  35. LANGE, S. & BENDER, R. (2007):   Was ist ein Signifikanztest? Allgemeine Aspekte.   Dtsch. Med. Wschr. 132, e19-e21.   Open Access
  36. BENDER, R. & LANGE, S. (2007):   Verlaufskurven.   Dtsch. Med. Wschr. 132, e22-e23.   Open Access
  37. BENDER, R., LANGE, S. & ZIEGLER, A. (2007):   Wichtige Signifikanztests.   Dtsch. Med. Wschr. 132, e24-e25.   Open Access
  38. BENDER, R., LANGE, S. & ZIEGLER, A. (2007):   Multiples Testen.   Dtsch. Med. Wschr. 132, e26-e29.   Open Access
  39. BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Multiple Regression.   Dtsch. Med. Wschr. 132, e30-e32.   Open Access
  40. BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Logistische Regression.   Dtsch. Med. Wschr. 132, e33-e35.   Open Access
  41. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Überlebenszeitanalyse: Eigenschaften und Kaplan-Meier Methode.   Dtsch. Med. Wschr. 132, e36-e38.   Open Access
  42. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Überlebenszeitanalyse: Der Log-Rang-Test.   Dtsch. Med. Wschr. 132, e38-e41.   Open Access
  43. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Überlebenszeitanalyse: Die Cox-Regression.   Dtsch. Med. Wschr. 132, e42-e44.   Open Access
  44. KLUG, S., BENDER, R., BLETTNER, M. & LANGE, S. (2007):   Wichtige epidemiologische Studientypen.   Dtsch. Med. Wschr. 132, e45-e47.   Open Access
  45. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Systematische Übersichten und Meta-Analysen.   Dtsch. Med. Wschr. 132, e48-e52.   Open Access
  46. LANGE, S., BENDER, R. & ZIEGLER, A. (2007):   Äquivalenzstudien und Nichtunterlegen­heitsstudien.   Dtsch. Med. Wschr. 132, e53-e56.   Open Access
  47. BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Varianzanalyse.   Dtsch. Med. Wschr. 132, e57-e60.   Open Access
  48. BENDER, R., GROUVEN & ZIEGLER, A. (2007):   Varianzanalyse für Messwertwiederholungen.   Dtsch. Med. Wschr. 132, e61-e64.   Open Access
  49. GROUVEN, U., BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Der Kappa-Koeffizient.   Dtsch. Med. Wschr. 132, e65-e68.   Open Access
  50. GROUVEN, BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Vergleich von Messmethoden.   Dtsch. Med. Wschr. 132, e69-e73.   Open Access
  51. KÜCHENHOFF, H., BENDER, R. & LANGNER, I. (2007):
    Effect of Berkson measurement error on parameter estimates in Cox regression models.
    Lifetime Data Anal. 13, 261-272.
  52. KUTSCHMANN, M., BENDER, R., GROUVEN, U. & BERG, G. (2006):
    Aspekte der Fallzahlkalkulation und Powerberechnung anhand von Beispielen aus der rehabilitationswissenschaftlichen Forschung.
    Rehabilitation 45, 377-384.
  53. BENDER, R., ZEEB, H., SCHWARZ, M., JÖCKEL, K.-H. & BERGER, M. (2006):
    Causes of death in obesity: Relevant increase in cardiovascular but not in all-cancer mortality.
    J. Clin. Epidemiol. 59, 1064-1071.
  54. HILDEBRANDT, M., BENDER, R., GEHRMANN, U. & BLETTNER, M. (2006):
    Calculating confidence intervals for impact numbers.
    BMC Med. Res. Methodol. 6, 32.   Open Access   Highly accessed
  55. BENDER, R., HILDEBRANDT, M. & KUSS, O. (2006):
    Die Berechnung adjustierter NNEs in Kohortenstudien.
    In: KAISER, K. & BÖDEKER, R.-H. (Eds.): Statistik und Datenanalyse mit SAS® − Proceedings der 10. Konferenz für SAS-Anwender in Forschung und Entwicklung (KSFE), pp. 19-33.  Shaker, Aachen.   Open Access
  56. BENDER, R. & GROUVEN, U. (2006):
    Möglichkeiten und Grenzen statistischer Regressionsmodelle zur Berechnung von Schwellenwerten für Mindestmengen.
    Z. ärztl. Fortbild. Qual. Gesundh.wes. 100, 93-98.
  57. SAWICKI, P.T., BENDER, R., SELKE, G.W., KLAUBER, J. & GUTSCHMIDT, S. (2006):
    Schätzung der unter Rofecoxib (Vioxx®) in Deutschland in den Jahren 2001-2004 aufgetretenen kardio- und zerebrovaskulären Ereignisse.
    Med. Klin. 101, 191-197 .
  58. BENDER, R., AUGUSTIN, T. & BLETTNER, H.(2005):
    Generating survival times to simulate Cox proportional hazards models.
     Stat. Med. 24, 1713-1723.    Corresponding Letter:   Stat. Med. 25 (2006), 1978-1979.
  59. BENDER, R., BERG, G. & ZEEB, H. (2005):
    Tutorial: Using confidence curves in medical research.
    Biom. J. 47, 237-247.
  60. MEYER, G., KÖPKE, S., BENDER, R., & MÜHLHAUSER, I. (2005):
    Predicting the risk of falling - efficacy of a risk assessment tool compared to nurses' judgement: A cluster-randomised controlled trial [ISRCTN37794278].
    BMC Geriatr. 5, 14.   Open Access
  61. SÄMANN, A., MÜHLHAUSER, I., BENDER, R., KLOOS, C & MÜLLER, U.A. (2005):
    Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: Prospective implementation study.
    Diabetologia 48, 1965-1970.   Open Access
  62. BENDER, R. (2005):   Number needed to treat (NNT).
    In:   ARMITAGE, P. & COLTON, T. (Eds.): Encyclopedia of Biostatistics, Vol. 6 (2nd Ed.), pp. 3752-3761.   Wiley, Chichester.
  63. WARNKE, A., MEYER, G., BENDER, R. & MÜHLHAUSER, I. (2004):
    Predictors of adherence to the use of hip protectors in nursing home residents.
     J. Am. Geriatr. Soc. 52, 340-345.
  64. LOBNIG, B.M., MASLOWSKA-WESSEL, E. & BENDER, R. (2003):
    Repeatability of heart rate variability measured via spectral analysis in healthy subjects.
     J. Clin. Basic Cardiol. 6, 29-33.   Open Access
  65. BENDER, R. & KUSS, O. (2003):
    Confidence intervals for adjusted NNEs: A simulation study (Letter).
    J. Clin. Epidemiol. 56, 205-206.
  66. SEYDEL, J., ULLRICH, A., BENDER, R., FISCHBACH, W. & BLETTNER, M. (2003):
    Helicobacter pylori and carcinogenesis of gastric B-cell lymphomas.
    Int. J. Cancer 104, 646-649.   Open Access
  67. MEYER, G., WARNKE, A., BENDER, R. & MÜHLHAUSER, I. (2003):
    Effect on hip fractures of increased use of hip protectors in nursing homes: Cluster randomised controlled trial.
    BMJ 326, 76-78.   Open Access
  68. BENDER, R., JÖCKEL, K.-H., RICHTER, B., SPRAUL, M. & BERGER, M. (2002):
    Body weight, blood pressure, and mortality in a cohort of obese patients.
     Am. J. Epidemiol. 156, 239-245.   Open Access
  69. BENDER, R. & BLETTNER, M. (2002):
    Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies.
    J. Clin. Epidemiol. 55, 525-530.
  70. BENDER, R. (2002):
    Reply to "Simple and effective confidence intervals for the number needed to treat".
    Control. Clin. Trials 23, 101-102.
  71. SADDIG, C., BENDER, R. & STARKE, A.A.R. (2002):
    A new classification plot for the C-peptide suppression test.
    J. Pancreas 3, 16-25.   Open Access
  72. MEINHOLD, J., MASLOWSKA-WESSEL, E., BENDER, R. & SAWOCKI, P.T. (2001):
    Low prevalence of cardiac autonomic neuropathy in Type 1 diabetic patients without nephropathy.
     Diabet. Med. 18, 607-613.
  73. BENDER, R. & LANGE, S. (2001):
    Adjusting for multiple testing - when and how ?
    J. Clin. Epidemiol. 54, 343-349.
  74. BENDER, R. (2001):
    Calculating confidence intervals for the number needed to treat.
    Control. Clin. Trials 22, 102-110.
  75. BENDER, R. (2001):
    Interpretation von Effizienzmaßen der Vierfeldertafel für Diagnostik und Behandlung.
    Med. Klin. 96, 116-121.     Correction:  Med. Klin. 96, 181.
  76. BENDER, R. (2000):
    Calculating summary measures of unimodal response curves by means of nonlinear regression models.
     J. Theor. Med. 2, 73-89.
  77. MÜHLHAUSER, I., OVERMANN, H., BENDER, R., JÖRGENS, V. & BERGER, M. (2000):
    Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
    Diabet. Med. 17, 727-734.
  78. MÜHLHAUSER, I., SAWICKI, P.T., BLANK, M., OVERMANN, H., BENDER, R. & BERGER, M. (2000):
    Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy.
    J. Intern. Med. 248, 333-341.   Open Access
  79. BENDER, R. & BENNER, A. (2000):
    Calculating ordinal regression models in SAS and S-Plus.
    Biom. J. 42, 677-699.
  80. BENDER, R. (2000):
    Improving the calculation of confidence intervals for the number needed to treat.
    In: HASMAN, A., BLOBEL, B., DUDECK, J., ENGELBRECHT, R., GELL, G. & PROKOSCH, H.-U. (Eds.): Medical Infobahn for Europe (Proc. of the MIE2000 and GMDS2000), pp. 29-32.
    IOS Press, Amsterdam.
  81. BENDER, R. (2000):
    Berechnung von Konfidenzintervallen für die Zahl "Number Needed to Treat" (NNT).
    In: BÖDEKER, R.-H. & HOLLENHORST, M. (Eds.): Proc. der 4. Konferenz für SAS-Anwender in Forschung und Entwicklung, pp. 1-7.
    AG Statistik des Inst. für Med. Informatik, Gießen.   Open Access
  82. RICHTER, B., BENDER, R. & BERGER, M.(2000):
    Effects of on-demand ß2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.
    J. Intern. Med. 247, 657-666.   Open Access
  83. SAWICKI, P.T., BENDER, R., BERGER, M. & MÜHLHAUSER, I. (2000):
    Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy.
    J. Intern. Med. 247, 131-138.   Open Access
  84. RICHTER, B. & BENDER, R. (2000):
    Kritische Bewertung von Theraphieverfahren.
    In: BERGER, M. (Hrsg.): Diabetes mellitus (2. Aufl.), pp. 223-233. Urban & Fischer, München.
  85. BENDER, R. & KIMMERLE, R. (1999):
    Assessment of glycemic thresholds for fetal macrosomia in pregnant diabetic women.
    In: VICTOR, N., BLETTNER, M., EDLER, L., HAUX, R., KNAUP-GREGORI, P., PRITSCH, M., WAHRENDORF, J., WINDELER, J. & ZIEGLER, S. (Eds.): Medical Informatics, Biostatistics and Epidemiology for Efficient Health Care and Medical Research (Contributions from the 44th Annual Conference of the GMDS), pp. 115-116.   Urban & Vogel, München.
  86. TROCHA, A., SCHMIDTKE, C., DIDJURGEIT, U., MÜHLHAUSER, I., BENDER, R., BERGER, M. & SAWICKI, P.T. (1999):
    Effects of intensified antihypertensive treatment in diabetic nephropathy: Mortality and morbidity results of a prospective controlled 10-year study.
    J. Hypertens. 17, 1497-1503.
  87. BENDER, R. (1999):
    Quantitative risk assessment in epidemiological studies investigating threshold effects.
    Biom. J. 41, 305-319.
  88. BENDER, R., JÖCKEL, K.-H., TRAUTNER, C., SPRAUL, M. & BERGER, M. (1999):
    Effect of age on excess mortality in obesity.
    JAMA 281, 1498-1504.   Open Access
  89. RAVE, K., BENDER, R., HEISE, T. & SAWICKI, P.T. (1999):
    Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.
    J. Hypertens. 17, 597-601.
  90. BENDER, R. & LANGE, S. (1999):
    Multiple test procedures other than Bonferroni's deserve wider use (Letter).
    BMJ 318, 600-601.
  91. KIMMMERLE, R., HEINEMANN, L., HEISE, T., BENDER, R., WEYER, C., HIRSCHBERGER, S. & BERGER, M. (1999):
    Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Menopause 6, 36-42.
  92. MÜHLHAUSER, I., OVERMANN, H., BENDER, R., BOTT, U., & BERGER, M. (1998):
    Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes - a prospective population based study.
    Diabetologia 41, 1274-1282.   Open Access
  93. MÜHLHAUSER, I., OVERMANN, H., BENDER, R., BOTT, U., JÖRGENS, V., TRAUTNER, C., SIEGRIST, J. & BERGER, M. (1998):
    Social status and the quality of care for adult people with Type I (insulin-dependent) diabetes mellitus - a population based study.
    Diabetologia 41, 1139-1150.   Open Access
  94. BENDER, R. & GROUVEN, U. (1998):
    Using binary logistic regression models for ordinal data with non-proportional odds.
    J. Clin. Epidemiol. 51, 809-816.
  95. BENDER, R., LANGE, S., FREITAG, M. & TRAMPISCH, H.J. (1998):
    Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence (Letter).
    Statist. Med. 17, 946-947.
  96. BENDER, R., TRAUTNER, C., SPRAUL, M. & BERGER, M. (1998):
    Assessment of excess mortality in obesity.
    Am. J. Epidemiol. 147, 42-48.   Open Access
  97. SAWICKI, P.T., KIWITT, S., BENDER, R. & BERGER, M. (1998):
    The value of the QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.
    J. Intern. Med. 243, 49-56.   Open Access
  98. BENDER, R. & GROUVEN, U. (1997):
    Ordinal logistic regression in medical research.
    J. R. Coll. Physic. London 31, 546-551.
  99. BENDER, R., TRAUTNER, C, SPRAUL, M. & BERGER, M. (1997):
    Die Übersterblichkeit bei Übergewicht − Die Düsseldorf Obesity Mortality Study (DOMS).
    In: MUCHE, R., BÜCHELE, G., HARDER, D. & GAUS, W. (Eds.): Medizinische Informatik, Biometrie und Epidemiologie − GMDS '97 (Proc. 42. Jahrestagung der GMDS e.V.), pp. 459-463.   MMV Medizin Verlag, München.
  100. BENDER, R. (1997):
    Square dance and probability (Letter).
    EAASDC Bull. 18 (No. 5), 19-20.
  101. BENDER, R. & GROUVEN, U. (1996):
    Logistic regression models used in medical research are poorly presented (Letter).
    BMJ 313, 628.
  102. BENDER, R. (1996):
    Calculating confidence intervals for summary measures of individual curves via nonlinear regression.
    Int. J. Biomed. Comput. 41, 13-18.
  103. BENDER, R. (1996):
    The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved (Letter).
    Diabetologia 39, 368-369.
  104. MÜHLHAUSER, I., BENDER, R., BOTT, U., JÖRGENS, V., GRÜSSER, M., WAGENER, W., OVERMANN, H. & BERGER, M. (1996):
    Cigarette smoking and progression of retinopathy and nephropathy in Type 1 diabetes.
    Diabet. Med. 13, 536-543.
  105. MÜHLHAUSER, I., PRANGE, K., SAWICKI, P.T., BENDER, R., DWORSCHAK, A., SCHADEN, W. & BERGER, M. (1996):
    Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
    Diabetologia 39, 212-219.
  106. SAWICKI, P.T., DÄHNE, R., BENDER, R. & BERGER, M. (1996):
    Prolonged QT interval as a predictor of mortality in diabetic nephropathy.
    Diabetologia 39, 77-81.
  107. BENDER, R. & SAWICKI, P.T. (1996):
    Effect of intensive treatment in insulin dependent diabetes mellitus with microalbuminuria (Letter).
    BMJ 312, 254.
  108. HEINEMANN, L., HEISE, T., KLEPPER, A., AMPUDIA, J., BENDER, R. & STARKE, A.A.R. (1995):
    Time action profiles of the intermediate-acting insulin analogue: Des(64,65)-human proinsulin.
    Diabetes Metab. 21, 415-419.
  109. BENDER, R. & HEINEMANN, L. (1995):
    Fitting nonlinear regression models with correlated errors to individual pharmacodynamic data using SAS software.
    J. Pharmacokin. Biopharm. 23, 87-100.
  110. SAWICKI, P.T., MÜHLHAUSER, I., DIDJURGEIT, U., BAUMGARTNER, A., BENDER, R. & BERGER, M. (1995):
    Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy.
    J. Hypertens. 13, 933-938.
  111. MÜHLHAUSER, I., BOTT, U., OVERMANN, H., WAGENER, W., BENDER, R., JÖRGENS, V. & BERGER, M. (1995):
    Liberalized diet in patients with type 1 diabetes.
    J. Intern. Med. 237, 591-597.
  112. KIMMERLE, R, ZAß, R.-P., SOMVILLE, T., BENDER, R., PAWLOWSKI, B. & BERGER, M. (1995):
    Pregnancies in women with diabetic nephropathy: Long-term outcome for mother and child.
    Diabetologia 38, 227-235.
  113. BENDER, R. & HEINEMANN, L. (1994):
    Description of peaked curves by means of exponential functions.
    In: PÖPPL, S.J., LIPINSKI, H.-G. & MANSKY, T. (Eds.): Medizinische Informatik: Ein integrierender Teil arztunterstützender Technologien (Proc. 38. Jahrestagung der GMDS e.V.), pp. 482-485.   MMV, München.
  114. BENDER, R. (1994):
    Determination of the area under a curve (Letter).
    Diabetes Care 17, 1223.
  115. SAWICKI, P.T., DIDJURGEIT, U., MÜHLHAUSER, I., BENDER, R., HEINEMANN, L. & BERGER, M. (1994):
    Smoking is associated with progression of diabetic nephropathy.
    Diabetes Care 17, 126-131.
  116. BENDER, R. (1993):
    Using common statistical program packages for the Friedman test when ties are among treatments and a multiple comparison procedure is needed.
    Comput. Statist. Data Anal. 16, 365-369.
  117. BENDER, R. & GROUVEN, U. (1993):
    On the choice of the number of residual autocovariances for the portmanteau test of multivariate autoregressive models.
    Commun. Statist. - B 22, 19-32.
  118. BENDER, R., SCHULTZ, B. & GROUVEN, U. (1993):
    Classification of EEG signals into general stages of anesthesia in real-time using autoregressive models.
    In: OPITZ, O., LAUSEN, B. & KLAR, R. (Eds.): Information and Classification: Concepts, Methods and Application (Proc. of the 16th Annual Conference of the "Gesellschaft für Klassifikation"), pp. 443-452.   Springer, Berlin.
  119. SCHULTZ, B., BENDER, R., SCHULTZ, A. & PICHLMAYR, I. (1992):
    Reduktion der Anzahl von EEG-Ableitung für ein routinemäßiges Monitoring auf der Intensivstation.
    Biomed. Techn. 37, 194-199.
  120. GROUVEN, U., BENDER, R., SCHULTZ, A. & PICHLMAYR, R. (1992):
    Application of adjusted survival curves to renal transplant data.
    Meth. Inf. Med. 31, 210-214.   Open Access
  121. BENDER, R., SCHULTZ, B., SCHULTZ, A. & PICHLMAYR, I. (1992):
    Testing the Gaussianity of the human EEG during anesthesia.
    Meth. Inf. Med. 31, 56-59.   Open Access
  122. BENDER, R., SCHULTZ, B., SCHULTZ, A. & PICHLMAYR, I. (1991):
    Identification of EEG patterns occuring in anesthesia by means of autoregressive parameters.
    Biomed. Techn. 36, 236-240.
  123. BENDER, R. & WOLTERING, F. (1991):
    Heritabilitätsschätzungen bei ordinalen Daten.
    Forschungsbericht Nr. 91/1, FB Statistik der Universität Dortmund.

Do you need a reprint?

Send me a request:   E-Mail Ralf.Bender@iqwig.de


Line


Back Back to my statistics page      Home Back to my start page


© 30.01.2012 Ralf Bender